ERAP1 structure, function and pathogenetic role in ankylosing spondylitis and other MHC-associated diseases

Molecular Immunology

Volumn 57, Issue 1, 2014, Pages 12-21

  Alvarez Navarro, Carlos ^a   López de Castro, José A ^a  

^a CSIC   (Spain)

Author keywords

Aminopeptidases; Ankylosing spondylitis; Antigen processing; ERAP1; HLA B27; Spondyloarthropathies

Indexed keywords

AMINOPEPTIDASE; CYTOKINE RECEPTOR; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; EPITOPE; HLA B27 ANTIGEN; LIGAND; UNCLASSIFIED DRUG;

ALLELE; ANGIOGENESIS; ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; BEHCET DISEASE; BLOOD PRESSURE REGULATION; CANCER CONTROL; CROSS PRESENTATION; CYTOPLASM; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME POLYMORPHISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; EPISTASIS; HOST RESISTANCE; HUMAN; HYPERTENSION; IMMUNITY; IMMUNOSURVEILLANCE; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PSORIASIS; REVIEW;

AMINOPEPTIDASES; ANKYLOSING SPONDYLITIS; ANTIGEN PROCESSING; ERAP1; HLA-B27; SPONDYLOARTHROPATHIES;

ALLELES; AMINOPEPTIDASES; ANIMALS; ENDOPLASMIC RETICULUM; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; MACROPHAGE ACTIVATION; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING;

EID: 84884413079     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.06.012     Document Type: Review

References (120)

1. Adamik B., Islam A., Rouhani F.N., Hawari F.I., Zhang J., Levine S.J. An association between RBMX, a heterogeneous nuclear ribonucleoprotein, and ARTS-1 regulates extracellular TNFR1 release. Biochemical and Biophysical Research Communications 2008, 371:505-509.
2. Akada T., Yamazaki T., Miyashita H., Niizeki O., Abe M., Sato A., Satomi S., Sato Y. Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) is involved in the activation of endothelial integrins. Journal of Cellular Physiology 2002, 193:253-262.
3. Allen R.L., O'Callaghan C.A., McMichael A.J., Bowness P. Cutting edge: HLA-B27 can form a novel β2-microglobulin-free heavy chain homodimer structure. Journal of Immunology 1999, 162:5045-5048.
4. Bird L.A., Peh C.A., Kollnberger S., Elliott T., McMichael A.J., Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. European Journal of Immunology 2003, 33:748-759.
5. Blanchard N., Gonzalez F., Schaeffer M., Joncker N.T., Cheng T., Shastri A.J., Robey E.A., Shastri N. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nature Immunology 2008, 9:937-944.
6. Blanchard N., Kanaseki T., Escobar H., Delebecque F., Nagarajan N.A., Reyes-Vargas E., Crockett D.K., Raulet D.H., Delgado J.C., Shastri N. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. Journal of Immunology 2010, 184:3033-3042.
7. Bluestone J.A., Herold K., Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010, 464:1293-1300.
8. Blum J.S., Wearsch P.A., Cresswell P. Pathways of antigen processing. Annual Review of Immunology 2013, 31:443-473.
9. Brown M.A. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology 2008, 47:132-137.
10. Brynedal B., Duvefelt K., Jonasdottir G., Roos I.M., Akesson E., Palmgren J., Hillert J. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2007, 2:e664.
11. Burfoot R.K., Jensen C.J., Field J., Stankovich J., Varney M.D., Johnson L.J., Butzkueven H., Booth D., Bahlo M., Tait B.D., Taylor B.V., Speed T.P., Heard R., Stewart G.J., Foote S.J., Kilpatrick T.J., Rubio J.P. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 2008, 71:42-50.
12. Chang S.C., Momburg F., Bhutani N., Goldberg A.L. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:17107-17112.
13. Choi C.B., Kim T.H., Jun J.B., Lee H.S., Shim S.C., Lee B., Pope A., Uddin M., Rahman P., Inman R.D. ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans. Annals of the Rheumatic Diseases 2010, 69:582-584.
14. Cifaldi L., Lo M.E., Forloni M., Giorda E., Lorenzi S., Petrini S., Tremante E., Pende D., Locatelli F., Giacomini P., Fruci D. Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing. Cancer Research 2011, 71:1597-1606.
15. Colbert R.A., DeLay M.L., Klenk E.I., Layh-Schmitt G. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunological Reviews 2010, 233:181-202.
16. Cui X., Hawari F., Alsaaty S., Lawrence M., Combs C.A., Geng W., Rouhani F.N., Miskinis D., Levine S.J. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. Journal of Clinical Investigation 2002, 110:515-526.
17. Cui X., Rouhani F.N., Hawari F., Levine S.J. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. Journal of Biological Chemistry 2003, 278:28677-28685.
18. Cui X., Rouhani F.N., Hawari F., Levine S.J. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. Journal of Immunology 2003, 171:6814-6819.
19. de Menthon M., LaValley M.P., Maldini C., Guillevin L., Mahr A. HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis and Rheumatism 2009, 61:1287-1296.
20. Draenert R., Le Gall S., Pfafferott K.J., Leslie A.J., Chetty P., Brander C., Holmes E.C., Chang S.C., Feeney M.E., Addo M.M., Ruiz L., Ramduth D., Jeena P., Altfeld M., Thomas S., Tang Y., Verrill C.L., Dixon C., Prado J.G., Kiepiela P., Martinez-Picado J., Walker B.D., Goulder P.J. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. Journal of Experimental Medicine 2004, 199:905-915.
21. Dragovic S.M., Hill T., Christianson G.J., Kim S., Elliott T., Scott D., Roopenian D.C., Van Kaer L., Joyce S. Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigens. Journal of Immunology 2011, 186:6683-6692.
22. Dyment D.A., Herrera B.M., Cader M.Z., Willer C.J., Lincoln M.R., Sadovnick A.D., Risch N., Ebers G.C. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Human Molecular Genetics 2005, 14:2019-2026.
23. Elliott T., Williams A. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunological Reviews 2005, 207:89-99.
24. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., Mychaleckyj J.C., Todd J.A., Bonella P., Fear A.L., Lavant E., Louey A., Moonsamy P. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
25. Evnouchidou I., Momburg F., Papakyriakou A., Chroni A., Leondiadis L., Chang S.C., Goldberg A.L., Stratikos E. The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1. PLoS ONE 2008, 3:e3658.
26. Evnouchidou I., Kamal R.P., Seregin S.S., Goto Y., Tsujimoto M., Hattori A., Voulgari P.V., Drosos A.A., Amalfitano A., York I.A., Stratikos E. Cutting edge: coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. Journal of Immunology 2011, 186:1909-1913.
27. Fierabracci A., Milillo A., Locatelli F., Fruci D. The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies. Autoimmunity Reviews 2012, 12:281-288.
28. Firat E., Saveanu L., Aichele P., Staeheli P., Huai J., Gaedicke S., Nil A., Besin G., Kanzler B., van Endert P., Niedermann G. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. Journal of Immunology 2007, 178:2241-2248.
29. Fogdell-Hahn A., Ligers A., Gronning M., Hillert J., Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000, 55:140-148.
30. Fruci D., Ferracuti S., Limongi M.Z., Cunsolo V., Giorda E., Fraioli R., Sibilio L., Carroll O., Hattori A., Van Endert P.M., Giacomini P. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. Journal of Immunology 2006, 176:4869-4879.
31. Fruci D., Giacomini P., Nicotra M.R., Forloni M., Fraioli R., Saveanu L., van Endert P., Natali P.G. Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues. Journal of Cellular Physiology 2008, 216:742-749.
32. Fung E.Y., Smyth D.J., Howson J.M., Cooper J.D., Walker N.M., Stevens H., Wicker L.S., Todd J.A. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes and Immunity 2009, 10:188-191.
33. Galocha B., López de Castro J.A. Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27. Journal of Biological Chemistry 2010, 285:39180-39190.
34. Gandhi A., Lakshminarasimhan D., Sun Y., Guo H.C. Structural insights into the molecular ruler mechanism of the endoplasmic reticulum aminopeptidase ERAP1. Scientific Reports 2011, 1:186.
35. Garcia-Medel N., Sanz-Bravo A., Van Nguyen D., Galocha B., Gomez-Molina P., Martin-Esteban A., Alvarez-Navarro C., López de Castro J.A. Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Molecular and Cellular Proteomics 2012, 11:1416-1429.
36. Garrido F., Cabrera T., Aptsiauri N. "Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy. International Journal of Cancer 2010, 127:249-256.
37. Goto Y., Hattori A., Ishii Y., Tsujimoto M. Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Letters 2006, 580:1833-1838.
38. Goto Y., Tanji H., Hattori A., Tsujimoto M. Glutamine-181 is crucial in the enzymatic activity and substrate specificity of human endoplasmic-reticulum aminopeptidase-1. Biochemical Journal 2008, 416:109-116.
39. Goto Y., Ogawa K., Hattori A., Tsujimoto M. Secretion of endoplasmic reticulum aminopeptidase 1 is involved in the activation of macrophages induced by lipopolysaccharide and interferon-gamma. Journal of Biological Chemistry 2011, 286:21906-21914.
40. Gudjonsson J.E., Karason A., Runarsdottir E.H., Antonsdottir A.A., Hauksson V.B., Jonsson H.H., Gulcher J., Stefansson K., Valdimarsson H. Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C- and HLA-B-typed patients. Journal of Investigative Dermatology 2006, 126:740-745.
41. Guerini F.R., Cagliani R., Forni D., Agliardi C., Caputo D., Cassinotti A., Galimberti D., Fenoglio C., Biasin M., Asselta R., Scarpini E., Comi G.P., Bresolin N., Clerici M., Sironi M. A functional variant in ERAP1 predisposes to multiple sclerosis. PLoS ONE 2012, 7:e29931.
42. Gul A., Ohno S. HLA-B*51 and Behcet disease. Ocular Immunology and Inflammation 2012, 20:37-43.
43. Hammer G.E., Gonzalez F., Champsaur M., Cado D., Shastri N. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nature Immunology 2006, 7:103-112.
44. Hammer G.E., Gonzalez F., James E., Nolla H., Shastri N. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nature Immunology 2007, 8:101-108.
45. Harbo H.F., Lie B.A., Sawcer S., Celius E.G., Dai K.Z., Oturai A., Hillert J., Lorentzen A.R., Laaksonen M., Myhr K.M., Ryder L.P., Fredrikson S., Nyland H., Sorensen P.S., Sandberg-Wollheim M., Andersen O., Svejgaard A., Edland A., Mellgren S.I., Compston A., Vartdal F., Spurkland A. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004, 63:237-247.
46. Haroon N., Tsui F.W., Chiu B., Tsui H.W., Inman R.D. Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms. Journal of Rheumatology 2010, 37:1907-1910.
47. Haroon N., Tsui F.W., Uchanska-Ziegler B., Ziegler A., Inman R.D. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Annals of the Rheumatic Diseases 2012, 71:589-595.
48. Harvey D., Pointon J.J., Evans D.M., Karaderi T., Farrar C., Appleton L.H., Sturrock R.D., Stone M.A., Oppermann U., Brown M.A., Wordsworth B.P. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Human Molecular Genetics 2009, 18:4204-4212.
49. Hattori A., Matsumoto H., Mizutani S., Tsujimoto M. Molecular cloning of adipocyte-derived leucine aminopeptidase highly related to placental leucine aminopeptidase/oxytocinase. Journal of Biochemistry 1999, 125:931-938.
50. Hattori A., Kitatani K., Matsumoto H., Miyazawa S., Rogi T., Tsuruoka N., Mizutani S., Natori Y., Tsujimoto M. Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells. Journal of Biochemistry 2000, 128:755-762.
51. Hattori A., Matsumoto K., Mizutani S., Tsujimoto M. Genomic organization of the human adipocyte-derived leucine aminopeptidase gene and its relationship to the placental leucine aminopeptidase/oxytocinase gene 10. Journal of Biochemistry 2001, 130:235-241.
52. Hattori A., Goto Y., Tsujimoto M. Exon 10 coding sequence is important for endoplasmic reticulum retention of endoplasmic reticulum aminopeptidase 1. Biological and Pharmaceutical Bulletin 2012, 35:601-605.
53. Hearn A., York I.A., Rock K.L. The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum. Journal of Immunology 2009, 183:5526-5536.
54. Henseler T., Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology 1985, 13:450-456.
55. Infantes S., Samino Y., Lorente E., Jimenez M., Garcia R., Del Val M., Lopez D. H-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing. Journal of Immunology 2010, 184:3351-3355.
56. Islam A., Adamik B., Hawari F.I., Ma G., Rouhani F.N., Zhang J., Levine S.J. Extracellular TNFR1 release requires the calcium-dependent formation of a nucleobindin 2-ARTS-1 complex. Journal of Biological Chemistry 2006, 281:6860-6873.
57. James E., Bailey I., Sugiyarto G., Elliott T. Induction of protective antitumor immunity through attenuation of ERAAP function. Journal of Immunology 2013, 190:5839-5846.
58. Julia A., Tortosa R., Hernanz J.M., Canete J.D., Fonseca E., Ferrandiz C., Unamuno P., Puig L., Fernandez-Sueiro J.L., Sanmarti R., Rodriguez J., Gratacos J., Dauden E., Sanchez-Carazo J.L., Lopez-Estebaranz J.L., Moreno-Ramirez D., Queiro R., Montilla C., Torre-Alonso J.C., Perez-Venegas J.J., Vanaclocha F., Herrera E., Munoz-Fernandez S., Gonzalez C., Roig D., Erra A., Acosta I., Fernandez-Nebro A., Zarco P., Alonso A., Lopez-Lasanta M., Garcia-Montero A., Gelpi J.L., Absher D., Marsal S. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes. Human Molecular Genetics 2012, 21:4549-4557.
59. Kamphausen E., Kellert C., Abbas T., Akkad N., Tenzer S., Pawelec G., Schild H., van Endert P., Seliger B. Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma. Cancer Immunology, Immunotherapy 2010, 59:1273-1284.
60. Kanaseki T., Blanchard N., Hammer G.E., Gonzalez F., Shastri N. ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity 2006, 25:795-806.
61. Kaneko S., Suzuki N., Yamashita N., Nagafuchi H., Nakajima T., Wakisaka S., Yamamoto S., Sakane T. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clinical and Experimental Immunology 1997, 108:204-212.
62. Kaneko F., Togashi A., Saito S., Sakuma H., Oyama N., Nakamura K., Yokota K., Oguma K. Behcet's disease (Adamantiades-Behcet's disease). Clinical and Developmental Immunology 2011, 2011:681956.
63. Kazeto H., Nomura S., Ito N., Ito T., Watanabe Y., Kajiyama H., Shibata K., Ino K., Tamakoshi K., Hattori A., Kikkawa F., Nagasaka T., Tsujimoto M., Mizutani S. Expression of adipocyte-derived leucine aminopeptidase in endometrial cancer. Association with tumor grade and CA-125. Tumour Biology 2003, 24:203-208.
64. Kim S., Lee S., Shin J., Kim Y., Evnouchidou I., Kim D., Kim Y.K., Kim Y.E., Ahn J.H., Riddell S.R., Stratikos E., Kim V.N., Ahn K. Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nature Immunology 2011, 12:984-991.
65. Kirino Y., Bertsias G., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., Ozyazgan Y., Sacli F.S., Erer B., Inoko H., Emrence Z., Cakar A., Abaci N., Ustek D., Satorius C., Ueda A., Takeno M., Kim Y., Wood G.M., Ombrello M.J., Meguro A., Gul A., Remmers E.F., Kastner D.L. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nature Genetics 2013, 45:202-207.
66. Kochan G., Krojer T., Harvey D., Fischer R., Chen L., Vollmar M., von Delft F., Kavanagh K.L., Brown M.A., Bowness P., Wordsworth P., Kessler B.M., Oppermann U. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:7745-7750.
67. Kollnberger S., Bowness P. The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis. Advances in Experimental Medicine and Biology 2009, 649:277-285.
68. Lin Z., Bei J.X., Shen M., Li Q., Liao Z., Zhang Y., Lv Q., Wei Q., Low H.Q., Guo Y.M., Cao S., Yang M., Hu Z., Xu M., Wang X., Wei Y., Li L., Li C., Li T., Huang J., Pan Y., Jin O., Wu Y., Wu J., Guo Z., He P., Hu S., Wu H., Song H., Zhan F., Liu S., Gao G., Liu Z., Li Y., Xiao C., Li J., Ye Z., He W., Liu D., Shen L., Huang A., Wu H., Tao Y., Pan X., Yu B., Tai E.S., Zeng Y.X., Ren E.C., Shen Y., Liu J., Gu J. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nature Genetics 2012, 44:73-77.
69. Lincoln M.R., Montpetit A., Cader M.Z., Saarela J., Dyment D.A., Tiislar M., Ferretti V., Tienari P.J., Sadovnick A.D., Peltonen L., Ebers G.C., Hudson T.J. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nature Genetics 2005, 37:1108-1112.
70. Lysell J., Padyukov L., Kockum I., Nikamo P., Stahle M. Genetic association with ERAP1 in psoriasis is confined to disease onset after puberty and not dependent on HLA-C*06. Journal of Investigative Dermatology 2013, 133:411-417.
71. Maksymowych W.P., Inman R.D., Gladman D.D., Reeve J.P., Pope A., Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis and Rheumatism 2009, 60:1317-1323.
72. Mantegazza A.R., Magalhaes J.G., Amigorena S., Marks M.S. Presentation of phagocytosed antigens by MHC class I and II. Traffic 2013, 14:135-152.
73. Marcilla M., Lopez de Castro J.A. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens 2008, 71:495-506.
74. Mear J.P., Schreiber K.L., Münz C., Zhu X., Stevanovic S., Rammensee H.G., Rowland-Jones S.L., Colbert R.A. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. Journal of Immunology 1999, 163:6665-6670.
75. Mehta A.M., Jordanova E.S., van Wezel T., Uh H.W., Corver W.E., Kwappenberg K.M., Verduijn W., Kenter G.G., van der Burg S.H., Fleuren G.J. Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes, Chromosomes and Cancer 2007, 46:577-586.
76. Mehta A.M., Jordanova E.S., Kenter G.G., Ferrone S., Fleuren G.J. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunology, Immunotherapy 2008, 57:197-206.
77. Mehta A.M., Jordanova E.S., Corver W.E., van Wezel T., Uh H.W., Kenter G.G., Jan F.G. Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma. Genes, Chromosomes and Cancer 2009, 48:410-418.
78. Miyashita H., Yamazaki T., Akada T., Niizeki O., Ogawa M., Nishikawa S., Sato Y. A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis. Blood 2002, 99:3241-3249.
79. Momburg F., Roelse J., Howard J.C., Butcher G.W., Hammerling G.J., Neefjes J.J. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994, 367:648-651.
80. Nejentsev S., Howson J.M., Walker N.M., Szeszko J., Field S.F., Stevens H.E., Reynolds P., Hardy M., King E., Masters J., Hulme J., Maier L.M., Smyth D., Bailey R., Cooper J.D., Ribas G., Campbell R.D., Clayton D.G., Todd J.A. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007, 450:887-892.
81. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. New England Journal of Medicine 2009, 361:496-509.
82. Nguyen T.T., Chang S.C., Evnouchidou I., York I.A., Zikos C., Rock K.L., Goldberg A.L., Stratikos E., Stern L.J. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nature Structural & Molecular Biology 2011, 18:604-613.
83. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. American Journal of Human Genetics 1996, 59:1134-1148.
84. Noble J.A., Valdes A.M., Varney M.D., Carlson J.A., Moonsamy P., Fear A.L., Lane J.A., Lavant E., Rappner R., Louey A., Concannon P., Mychaleckyj J.C., Erlich H.A. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 2010, 59:2972-2979.
85. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991, 38:1-15.
86. Payeli S.K., Kollnberger S., Marroquin B.O., Thiel M., McHugh K., Giles J., Shaw J., Kleber S., Ridley A., Wong-Baeza I., Keidel S., Kuroki K., Maenaka K., Wadle A., Renner C., Bowness P. Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis. Arthritis and Rheumatism 2012, 64:3139-3149.
87. Pervin K., Childerstone A., Shinnick T., Mizushima Y., van der Z.R., Hasan A., Vaughan R., Lehner T. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease. Journal of Immunology 1993, 151:2273-2282.
88. Pimentel-Santos F.M., Ligeiro D., Matos M., Mourao A.F., Sousa E., Pinto P., Ribeiro A., Sousa M., Barcelos A., Godinho F., Cruz M., Fonseca J.E., Guedes-Pinto H., Trindade H., Evans D.M., Brown M.A., Branco J.C. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clinical and Experimental Rheumatology 2009, 27:800-806.
89. Reeves E., Edwards C.J., Elliott T., James E. Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. Journal of Immunology 2013, 10.4049/jimmunol.1300598.
90. Reveille J.D., Sims A.M., Danoy P., Evans D.M., Leo P., Pointon J.J., Jin R., Zhou X., Bradbury L.A., Appleton L.H., Davis J.C., Diekman L., Doan T., Dowling A., Duan R., Duncan E.L., Farrar C., Hadler J., Harvey D., Karaderi T., Mogg R., Pomeroy E., Pryce K., Taylor J., Savage L., Deloukas P., Kumanduri V., Peltonen L., Ring S.M., Whittaker P., Glazov E., Thomas G.P., Maksymowych W.P., Inman R.D., Ward M.M., Stone M.A., Weisman M.H., Wordsworth B.P., Brown M.A. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nature Genetics 2010, 42:123-127.
91. Rock K.L., York I.A., Saric T., Goldberg A.L. Protein degradation and the generation of MHC class I-presented peptides. Advances in Immunology 2002, 80:1-70.
92. Sakane T., Takeno M., Suzuki N., Inaba G. Behcet's disease. New England Journal of Medicine 1999, 341:1284-1291.
93. Saric T., Chang S.C., Hattori A., York I.A., Markant S., Rock K.L., Tsujimoto M., Goldberg A.L. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nature Immunology 2002, 3:1169-1176.
94. Saveanu L., Carroll O., Lindo V., Del Val M., Lopez D., Lepelletier Y., Greer F., Schomburg L., Fruci D., Niedermann G., Van Endert P.M. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nature Immunology 2005, 6:689-697.
95. Serwold T., Gaw S., Shastri N. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nature Immunology 2001, 2:644-651.
96. Serwold T., Gonzalez F., Kim J., Jacob R., Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002, 419:480-483.
97. Shibata K., Kikkawa F., Mizokami Y., Kajiyama H., Ino K., Nomura S., Mizutani S. Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma. Tumour Biology 2005, 26:9-16.
98. Spencer C.T., Dragovic S.M., Conant S.B., Gray J.J., Zheng M., Samir P., Niu X., Moutaftsi M., Van Kaer L., Sette A., Link A.J., Joyce S. Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses. European Journal of Immunology 2013, 43:1162-1172.
99. Stanford M.R., Kasp E., Whiston R., Hasan A., Todryk S., Shinnick T., Mizushima Y., Dumonde D.C., van der Z.R., Lehner T. Heat shock protein peptides reactive in patients with Behcet's disease are uveitogenic in Lewis rats. Clinical and Experimental Immunology 1994, 97:226-231.
100. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., Barton A., Band G., Bellenguez C., Bergboer J.G., Blackwell J.M., Bramon E., Bumpstead S.J., Casas J.P., Cork M.J., Corvin A., Deloukas P., Dilthey A., Duncanson A., Edkins S., Estivill X., Fitzgerald O., Freeman C., Giardina E., Gray E., Hofer A., Huffmeier U., Hunt S.E., Irvine A.D., Jankowski J., Kirby B., Langford C., Lascorz J., Leman J., Leslie S., Mallbris L., Markus H.S., Mathew C.G., McLean W.H., McManus R., Mossner R., Moutsianas L., Naluai A.T., Nestle F.O., Novelli G., Onoufriadis A., Palmer C.N., Perricone C., Pirinen M., Plomin R., Potter S.C., Pujol R.M., Rautanen A., Riveira-Munoz E., Ryan A.W., Salmhofer W., Samuelsson L., Sawcer S.J., Schalkwijk J., Smith C.H., Stahle M., Su Z., Tazi-Ahnini R., Traupe H., Viswanathan A.C., Warren R.B., Weger W., Wolk K., Wood N., Worthington J., Young H.S., Zeeuwen P.L., Hayday A., Burden A.D., Griffiths C.E., Kere J., Reis A., McVean G., Evans D.M., Brown M.A., Barker J.N., Peltonen L., Donnelly P., Trembath R.C. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature Genetics 2010, 42:985-990.
101. Sun L.D., Cheng H., Wang Z.X., Zhang A.P., Wang P.G., Xu J.H., Zhu Q.X., Zhou H.S., Ellinghaus E., Zhang F.R., Pu X.M., Yang X.Q., Zhang J.Z., Xu A.E., Wu R.N., Xu L.M., Peng L., Helms C.A., Ren Y.Q., Zhang C., Zhang S.M., Nair R.P., Wang H.Y., Lin G.S., Stuart P.E., Fan X., Chen G., Tejasvi T., Li P., Zhu J., Li Z.M., Ge H.M., Weichenthal M., Ye W.Z., Zhang C., Shen S.K., Yang B.Q., Sun Y.Y., Li S.S., Lin Y., Jiang J.H., Li C.T., Chen R.X., Cheng J., Jiang X., Zhang P., Song W.M., Tang J., Zhang H.Q., Sun L., Cui J., Zhang L.J., Tang B., Huang F., Qin Q., Pei X.P., Zhou A.M., Shao L.M., Liu J.L., Zhang F.Y., Du W.D., Franke A., Bowcock A.M., Elder J.T., Liu J.J., Yang S., Zhang X.J. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nature Genetics 2010, 42:1005-1009.
102. Szczypiorska M., Sanchez A., Bartolome N., Arteta D., Sanz J., Brito E., Fernandez P., Collantes E., Martinez A., Tejedor D., Artieda M., Mulero J. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology 2011, 50:1969-1975.
103. Tan T.G., Mui E., Cong H., Witola W.H., Montpetit A., Muench S.P., Sidney J., Alexander J., Sette A., Grigg M.E., Maewal A., McLeod R. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine 2010, 28:3977-3989.
104. The IMSC and WTCCC2 Consortia Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
105. The TASK and WTCCC2 Consortia Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics 2011, 43:761-767.
106. Tsujimoto M., Hattori A. The oxytocinase subfamily of M1 aminopeptidases. Biochimica et Biophysica Acta 2005, 1751:9-18.
107. Urban S., Textoris-Taube K., Reimann B., Janek K., Dannenberg T., Ebstein F., Seifert C., Zhao F., Kessler J.H., Halenius A., Henklein P., Paschke J., Cadel S., Bernhard H., Ossendorp F., Foulon T., Schadendorf D., Paschen A., Seifert U. The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases. Journal of Immunology 2012, 189:529-538.
108. Van Endert P.M., Riganelli D., Greco G., Fleischhauer K., Sidney J., Sette A., Bach J.F. The peptide-binding motif for the human transporter associated with antigen processing. Journal of Experimental Medicine 1995, 182:1883-1895.
109. Wang C.M., Ho H.H., Chang S.W., Jan Wu Y.J., Lin J.C., Chang P.Y., Wu J., Chen J.Y. ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Research and Therapy 2012, 14:R125.
110. Watanabe Y., Shibata K., Kikkawa F., Kajiyama H., Ino K., Hattori A., Tsujimoto M., Mizutani S. Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system. Clinical Cancer Research 2003, 9:6497-6503.
111. Winchester R., Minevich G., Steshenko V., Kirby B., Kane D., Greenberg D.A., Fitzgerald O. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis and Rheumatism 2012, 64:1134-1144.
112. WTCC Consortium Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 2007, 39:1329-1337.
113. Yan J., Parekh V.V., Mendez-Fernandez Y., Olivares-Villagomez D., Dragovic S., Hill T., Roopenian D.C., Joyce S., Van Kaer L. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. Journal of Experimental Medicine 2006, 203:647-659.
114. Yang Q., Liu H., Qu L., Fu X., Yu Y., Yu G., Tian H., Yu Y., Sun D., Peng J., Bao F., Yuan C., Lu N., Li J., Zhang Y., Zhang F. Investigation of 20 non-HLA psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris. British Journal of Dermatology 2013, 168:1060-1065.
115. Yasuoka H., Okazaki Y., Kawakami Y., Hirakata M., Inoko H., Ikeda Y., Kuwana M. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behcet's disease. Arthritis and Rheumatism 2004, 50:3658-3662.
116. Yewdell J.W., Reits E., Neefjes J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nature Reviews Immunology 2003, 3:952-961.
117. York I.A., Chang S.C., Saric T., Keys J.A., Favreau J.M., Goldberg A.L., Rock K.L. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nature Immunology 2002, 3:1177-1184.
118. York I.A., Brehm M.A., Zendzian S., Towne C.F., Rock K.L. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:9202-9207.
119. Zernich D., Purcell A.W., Macdonald W.A., Kjer-Nielsen L., Ely L.K., Laham N., Crockford T., Mifsud N.A., Bharadwaj M., Chang L., Tait B.D., Holdsworth R., Brooks A.G., Bottomley S.P., Beddoe T., Peh C.A., Rossjohn J., McCluskey J. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. Journal of Experimental Medicine 2004, 200:13-24.
120. Zhang S.C., Martin E., Shimada M., Godfrey S.B., Fricke J., Locastro S., Lai N.Y., Liebesny P., Carlson J.M., Brumme C.J., Ogbechie O.A., Chen H., Walker B.D., Brumme Z.L., Kavanagh D.G., Le Gall S. Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals. Journal of Immunology 2012, 188:5924-5934.